Zhaoke Ophthalmology Limited (HKG:6622)

Zhaoke Ophthalmology Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	497.62	959.31	1,121	1,462	1,716	2,128
Short-Term Investments	218.21	1.5	70.16	-	8.87	8.16
Cash & Short-Term Investments	715.83	960.81	1,191	1,462	1,725	2,137
Cash Growth	-32.10%	-19.34%	-18.50%	-15.28%	-19.25%	145.21%
Accounts Receivable	5.64	14.1	1.38	3.71	-	-
Other Receivables	40.98	30.68	21.32	18.83	48.07	14.57
Receivables	46.61	44.78	22.7	22.54	48.07	14.57
Inventory	13.69	14.63	14.9	6.14	-	-
Restricted Cash	295.64	336.43	356.3	265.66	172.07	25.51
Other Current Assets	26.38	17.2	29.86	38.61	27.38	32.23
Total Current Assets	1,098	1,374	1,615	1,795	1,973	2,209
Property, Plant & Equipment	143.23	158.61	192.14	223.65	233.74	184.32
Other Intangible Assets	476.68	383.64	413.55	392.46	334.62	162.38
Other Long-Term Assets	19.96	19.22	22.91	9.66	29.51	49.81
Total Assets	1,738	1,935	2,244	2,420	2,571	2,605

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	1.55	1.93	2.78	9.27	11.05	14.69
Accrued Expenses	51.34	37.59	80.67	101.47	61.81	24.23
Short-Term Debt	248.88	270.37	212.61	206.58	94.5	10.29
Current Portion of Leases	11.27	12.58	9.93	9.59	9.73	5.88
Current Income Taxes Payable	3.95	0.75	1.06	-	-	5.53
Current Unearned Revenue	2.55	1.73	1.37	1.18	-	-
Other Current Liabilities	2.36	3.47	4.63	8.38	17.46	28.39
Total Current Liabilities	321.88	328.41	313.05	336.45	194.54	89.01
Long-Term Leases	6.42	9.4	16.05	21.86	27.7	20.86
Long-Term Unearned Revenue	21.44	21.49	14.21	13.71	0.01	0.05
Pension & Post-Retirement Benefits	0.12	0.12	0.13	-	-	-
Total Liabilities	349.86	359.43	343.44	372.02	222.25	109.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Additional Paid-In Capital	-	5,454	5,444	5,444	5,428	5,414
Retained Earnings	-	-4,238	-4,035	-3,807	-3,429	-3,022
Comprehensive Income & Other	1,388	359.99	491.19	411.54	350.14	103.48
Shareholders' Equity	1,388	1,576	1,900	2,048	2,348	2,495
Total Liabilities & Equity	1,738	1,935	2,244	2,420	2,571	2,605

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	266.56	292.36	238.59	238.03	131.93	37.03
Net Cash (Debt)	449.27	668.46	952.57	1,224	1,593	2,100
Net Cash Growth	-42.61%	-29.83%	-22.15%	-23.20%	-24.11%	-
Net Cash Per Share	0.82	1.22	1.74	2.25	2.94	5.09
Filing Date Shares Outstanding	548.48	548.75	546.14	546.14	543.84	541.95
Total Common Shares Outstanding	548.48	548.75	546.14	546.14	543.84	541.95
Working Capital	776.27	1,045	1,302	1,458	1,778	2,120
Book Value Per Share	2.53	2.87	3.48	3.75	4.32	4.60
Tangible Book Value	911.48	1,192	1,487	1,656	2,014	2,333
Tangible Book Value Per Share	1.66	2.17	2.72	3.03	3.70	4.31
Machinery	-	282.76	279.81	264.6	208.55	186.33
Construction In Progress	-	20.9	20.76	32.38	61.42	18.33
Leasehold Improvements	-	7.4	7.57	7.46	7.38	7.12

Data Source: S&P Global Market Intelligence Last updated: Aug 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 20, 2026

Data Sources Report a data error